Manufacturing neurons from human embryonic stem cells: Biological and regulatory aspects to develop a safe cellular product for stroke cell therapy

Regenerative Medicine

Volumn 4, Issue 2, 2009, Pages 251-263

  Daadi, Marcel M ^a   Steinberg, Gary K ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford California and Cofounder   (United States)

Author keywords

Cell therapy; cGMP; Good manufacturing practice; Human embryonic stem cells; Human neural stem cells; Investigational new drug application; Manufacturing neurons; Master cell bank; Neuroplasticity; Pproduct development; Regulation of stem cell products; Stroke

Indexed keywords

BIOENGINEERING; BRAIN BLOOD FLOW; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL RENEWAL; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; EMBRYONIC STEM CELL; GOOD MANUFACTURING PRACTICE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; MIDDLE CEREBRAL ARTERY; NERVE CELL PLASTICITY; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; CELL TRANSPLANTATION; CULTURE TECHNIQUE; CYTOLOGY; METHODOLOGY; NERVE CELL; STROKE;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL TRANSPLANTATION; EMBRYONIC STEM CELLS; HUMANS; NEURONS; STROKE;

EID: 65549115452     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.4.2.251     Document Type: Review

References (65)

1. International Summit on Transplant Tourism and Organ Trafficking. The declaration of Istanbul on organ trafficking and transplant tourism. Clin. J. Am. Soc. Nephrol. 3, 1227-1231 (2008).
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
3. Blum B, Benvenisty N: Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells 25, 1924-1930 (2007).
4. Przyborski SA: Differentiation of human embryonic stem cells after transplantation in immune-deficient mice. Stem Cells 23, 1242-1250 (2005).
5. Munoz-Sanjuan I, Brivanlou HA: Neural induction, the default model and embryonic stem cells. Nat. Rev. Neurosci. 3, 271-280 (2002).
6. Schulz TC, Palmarini GM, Noggle SA, Weiler DA, Mitalipova MM, Condie GB: Directed neuronal differentiation of human embryonic stem cells. BMC Neurosci. 4, 27 (2003).
7. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson AJ: In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 19, 1129-1133 (2001).
8. Perrier AL, Tabar V, Barberi T et al.: Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA 101, 12543-12548 (2004).
9. Tabar V, Panagiotakos G, Greenberg DE et al.: Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain. Nat. Biotechnol. 23, 601-606 (2005).
10. Pera MF, Andrade J, Houssami S et al.: Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J. Cell Sci. 117, 1269-1280 (2004).
11. Itsykson P, Ilouz N, Turetsky T et al.: Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Mol. Cell. Neurosci. 30, 24-36 (2005).
12. Reubinoff BE, Itsykson P, Turetsky T et al.: Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19, 1134-1140 (2001).
13. Nat R, Nilbratt M, Narkilahti S, Winblad B, Hovatta O, Nordberg A: Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures. Glia 55, 385-399 (2007).
14. Shin S, Mitalipova M, Noggle S et al.: Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells 24, 125-138 (2006).
15. Conti L, Pollard SM, Gorba T et al.: Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol. 3, E283 (2005).
16. Elkabetz Y, Panagiotakos G, Al Shamy G, Socci ND, Tabar V, Studer L: Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev. 22, 152-165 (2008).
17. Daadi MM, Maag AL, Steinberg KG: Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS ONE 3, E1644 (2008).
18. Glaser T, Pollard SM, Smith A, Brustle O: Tripotential differentiation of adherently expandable neural stem (NS) cells. PLoS ONE 2, E298 (2007).
19. NINDS-rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 333, 1581-1587 (1995).
20. Corbett D, Nurse S: The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog. Neurobiol. 54, 531-548 (1998).
21. Kondziolka D, Steinberg GK, Wechsler L et al.: Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial. J. Neurosurg. 103, 38-45 (2005).
22. Mendez I, Sanchez-Pernaute R, Cooper O et al.: Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128, 1498-1510 (2005).
23. Wenning GK, Odin P, Morrish P et al.: Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42, 95-107 (1997).
24. Nikkhah G, Olsson M, Eberhard J, Bentlage C, Cunningham MG, Bjorklund A: A microtransplantation approach for cell suspension grafting in the rat parkinson model - a detailed account of the methodology. Neuroscience 63, 57-72 (1994).
25. Endres M, Engelhardt B, Koistinaho J et al.: Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc. Dis. 25, 268-278 (2008).
26. Erdo F, Buhrle C, Blunk J et al.: Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J. Cereb. Blood Flow Metab. 23, 780-785 (2003).
27. Takagi Y, Nishimura M, Morizane A et al.: Survival and differentiation of neural progenitor cells derived from embryonic stem cells and transplanted into ischemic brain. J. Neurosurg. 103, 304-310 (2005).
28. Nonaka M, Yoshikawa M, Nishimura F et al.: Intraventricular transplantation of embryonic stem cell-derived neural stem cells in intracerebral hemorrhage rats. Neurol. Res. 26, 265-272 (2004).
29. Pruszak J, Sonntag KC, Aung MH, Sanchez-Pernaute R, Isacson O: Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells 25, 2257-2268 (2007).
30. Fukuda H, Takahashi J, Watanabe K et al.: Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells 24, 763-771 (2006).
31. Jung J, Hackett NR, Pergolizzi RG, Pierre-Destine L, Krause A, Crystal GR: Ablation of tumor-derived stem cells transplanted to the central nervous system by genetic modification of embryonic stem cells with a suicide gene. Hum. Gene Ther. 18, 1182-1192 (2007).
32. Cao F, Drukker M, Lin S et al.: Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning Stem Cells 9, 107-117 (2007).
33. Schuldiner M, Itskovitz-Eldor J, Benvenisty N: Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21, 257-265 (2003).
34. Wei L, Cui L, Snider JB et al.: Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol. Dis. 19, 183-193 (2005).
35. Buhnemann C, Scholz A, Bernreuther C et al.: Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 129, 3238-3248 (2006).
36. Li Z, McKercher SR, Cui J et al.: Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells. J. Neurosci. 28, 6557-6568 (2008).
37. Theus MH, Wei L, Cui L et al.: In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp. Neurol. 210, 656-670 (2008).
38. Nakatomi H, Kuriu T, Okabe S et al.: Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110, 429-441 (2002).
39. Liu J, Solway K, Messing RO, Sharp RF: Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 18, 7768-7778 (1998).
40. Zhang RL, Zhang ZG, Chopp M: Ischemic stroke and neurogenesis in the subventricular zone. Neuropharmacology 55, 345-352 (2008).
41. Parent JM, Vexler ZS, Gong C, Derugin N, Ferriero MD: Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann. Neurol. 52, 802-813 (2002).
42. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O: Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8, 963-970 (2002).
43. Jin K, Minami M, Lan QJ et al.: Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl Acad. Sci. USA 98, 4710-4715 (2001).
44. Plane JM, Liu R, Wang TW, Silverstein FS, Parent MJ: Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse. Neurobiol. Dis. 16, 585-595 (2004).
45. Thored P, Arvidsson A, Cacci E et al.: Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 24, 739-747 (2006).
46. Carmichael ST: Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann. Neurol. 59, 735-742 (2006).
47. Nudo RJ: Postinfarct cortical plasticity and behavioral recovery. Stroke 38, 840-845 (2007).
48. Emsley JG, Mitchell BD, Magavi SS, Arlotta P, Macklis DJ: The repair of complex neuronal circuitry by transplanted and endogenous precursors. NeuroRx 1, 452-471 (2004).
49. Aubert I, Ridet JL, Gage HF: Regeneration in the adult mammalian CNS: guided by development. Curr. Opin Neurobiol. 5, 625-635 (1995).
50. Chopp M, Li Y, Zhang J: Plasticity and remodeling of brain. J. Neurol. Sci. 265, 97-101 (2008).
51. Park KI, Teng YD, Snyder YE: The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol. 20, 1111-1117 (2002).
52. Capone C, Frigerio S, Fumagalli S et al.: Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment. PLoS ONE 2, E373 (2007).
53. Jiang Q, Zhang ZG, Ding LG et al.: Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. Neuroimage 28, 698-707 (2005).
54. Lee ST, Chu K, Jung HK et al.: Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 131, 616-629 (2008).
55. Baker M: Consent issues restrict stem-cell use. Nature 454(7204), 556 (2008).
56. Barker RA, Widner H: Immune problems in central nervous system cell therapy. NeuroRx 1, 472-481 (2004).
57. Fairchild PJ, Robertson NJ, Minger SL, Waldmann H: Embryonic stem cells: protecting pluripotency from alloreactivity. Curr. Opin. Immunol. 19, 596-602 (2007).
58. Hochedlinger K, Rideout WM, Kyba M, Daley GQ, Blelloch R, Jaenisch R: Nuclear transplantation, embryonic stem cells and the potential for cell therapy. Hematol J. 5(Suppl. 3), S114-S117 (2004).
59. Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H, Fairchild JP: Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl Acad. Sci. USA 104, 20920-20925 (2007).
60. Drukker M, Katchman H, Katz G et al.: Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24, 221-229 (2006).
61. Tian X, Woll PS, Morris JK, Linehan JL, Kaufman SD: Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 24, 1370-1380 (2006).
62. Hoehn M, Kustermann E, Blunk J et al.: Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl Acad. Sci. USA 99, 16267-16272 (2002).
63. Guzman R, Uchida N, Bliss MT et al.: Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc. Natl Acad. Sci. USA 104, 10211-10216 (2007).
64. de Vries IJ, Lesterhuis WJ, Barentsz OJ et al.: Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 23, 1407-1413 (2005).
65. Walczak P, Bulte WJ: The role of noninvasive cellular imaging in developing cell-based therapies for neurodegenerative disorders. Neurodegener. Dis. 4, 306-313 (2007)